Prof. Yıldız ERGİNER

Metrics

Publication

189

Citation (WoS)

273

H-Index (WoS)

Citation (Scopus)

291

H-Index (Scopus)

Project

Intellectual Property

Thesis Advisory

Open Access

UN Sustainable Development Goals

Education Information

1985 - 1989

Doctorate

Istanbul University, Faculty Of Pharmacy , Farmasötik Teknoloji Anabilim Dalı, Turkey

1982 - 1985

Postgraduate

Istanbul University, Faculty Of Pharmacy , Farmasötik Teknoloji Anabilim Dalı, Turkey

1978 - 1982

Undergraduate

Istanbul University, Faculty Of Pharmacy , Farmasötik Teknoloji Anabilim Dalı, Turkey

Dissertations

1989

Doctorate

HEPARİN ÜZERİNE ÇALIŞMALAR

Istanbul University, Faculty of Pharmacy , Farmasötik Teknoloji

1985

Postgraduate

ASPİRİN, NOVALJİN, KAFEİN TABLETLERİ HAZIRLANMASI ÜZERİNE ÇALIŞMALAR

Istanbul University, Faculty of Pharmacy , Farmasötik Teknoloji

Foreign Languages

B2 Upper Intermediate

English

Research Areas

Health Sciences

Pharmacology and Therapeutics

Pharmaceutics Technology

Pharmaceutical Biotechnology

Pharmaceutical Technology

Biopharmaceutical and Pharmacokinetics

Radiopharmacy

Academic Titles / Tasks

2006 - Continues

Professor

Istanbul University, Faculty of Pharmacy , Department of Pharmaceutical Technology

2000 - 2006

Associate Professor

Istanbul University, Faculty of Pharmacy , Department of Pharmaceutical Technology

1993 - 2000

Assistant Professor

İLAÇLARIN RUHSATLANDIRILMASI

Advising Theses

2021

Doctorate

Göze Ugulanmak Üzere İlaç Taşıyıcı Sistemlerin Tasarımı Hakkında Çalışmalar

Erginer Y. (Consultant)

B.ÜNER(Student)

2021

Doctorate

Çözünürlüğü düşük etken maddenin kendiliğinden emülsifiye olan yeni formülasyonlarının geliştirilmesi ve in vitro karakterizasyon çalışmaları

Erginer Y. (Consultant)

H.NAZLI(Student)

2019

Doctorate

Hipertrofik skar tedavisi için topikal formülasyonların tasarlanması

Erginer Y. (Co-Consultant), Özer K. Ö.

A.ASRAM(Student)

2019

Doctorate

Postgraduate

Siprofloksazin’in Kitozan ile mikro- ve nanopartiküllerinin hazırlanması ve nazal olarak uygulanması üzerine çalışmalar

ERGİNER Y.

D.Gürcan(Student)

Published journal articles indexed by SCI, SSCI, and AHCI

2022

Evaluation of the effect of different particle sizes of Mannitol on dissolution and tablet properties in the framework of QbD Dissolution Technologies

Mesut B., Pirinçci Tok Y., Alkan B., Al-Mohaya M., Kara M., Erginer Y.

DISSOLUTION TECHNOLOGIES, vol.3, no.1, pp.1, 2022 (SCI-Expanded)

2022

Optimization of the Micellar-Based In Situ Gelling Systems Posaconazole with Quality by Design (QbD) Approach and Characterization by In Vitro Studies

Durgun M. E. , Mesut B., Hacıoğlu M., Güngör S., Erginer Y.

PHARMACEUTICS, vol.14, no.3, pp.1, 2022 (SCI-Expanded)

2021

In vitro Evaluation of a Solid Supersaturated Self Nanoemulsifying Drug Delivery System (super-SNEDDS) of Aprepitant for Enhanced Solubility

Nazlı H., Mesut B., Erginer Y.

PHARMACEUTICALS, vol.1, no.1, pp.1, 2021 (SCI-Expanded)

2021

Posaconazole micelles for ocular delivery: in vitro permeation, ocular irritation and antifungal activity studies

Durgun M. E. , Kahraman E., Hacioglu M., Gungor S., Ozsoy Y.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2021 (SCI-Expanded)

2020

Design, optimization and characterization of novel topical formulations containing Triamcinolone Acetonide

Sagiroglu A. A. , Ozsoy Y., Ozer O.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, vol.58, 2020 (SCI-Expanded)

2020

Statistical Investigation of The Effect of Excipients Particle Size on Orally Disintegrating Tablets: Mannitol Grades

Mesut B., Başkor A., Pirinçci Tok Y., Alkan B., Erginer Y.

Informatica, vol.31, no.7, pp.69-91, 2020 (SCI-Expanded)

2020

Micelles: Promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases.

Durgun M., Güngör S., Özsoy Y.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, vol.36, pp.323-341, 2020 (SCI-Expanded)

2020

Budesonide-Loaded Self-Nanoemulsion Formulations Optimisation and Characterisation Studies

Mesut B., Tekarslan Şahin Ş. H. , Erginer Y.

Latin American Journal Of Pharmacy, vol.39, no.7, pp.1368-1378, 2020 (SCI-Expanded)

2020

Optimization and Characterization of Aqueous Micellar Formulations for Ocular Delivery of an Antifungal Drug, Posaconazole

Durgun M., Kahraman E., Güngör S., Özsoy Y.

CURRENT PHARMACEUTICAL DESIGN, vol.26, no.14, pp.1543-1555, 2020 (SCI-Expanded)

2019

Product transfer from lab-scale to pilot-scale of quetiapine fumarate orodispersible films using quality by design approach

Bulbul E. O. , Mesut B., Cevher E., Oztas E., Ozsoy Y.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, vol.54, 2019 (SCI-Expanded)

2017

Inhaled Heparin: Therapeutic Efficacy and Recent Formulations

Yildiz-Pekoz A., Ozsoy Y.

JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, vol.30, no.3, pp.143-156, 2017 (SCI-Expanded)

2017

Advances in Micelle-based Drug Delivery: Cross-linked Systems

İŞOĞLU İ. A. , Ozsoy Y., DİNÇER İŞOĞLU S.

CURRENT TOPICS IN MEDICINAL CHEMISTRY, vol.17, no.13, pp.1469-1489, 2017 (SCI-Expanded)

2016

Micelle Mixtures for Coadministration of Gemcitabine and GDC-0449 To Treat Pancreatic Cancer

Karaca M., Dutta R., Ozsoy Y., Mahato R. I.

MOLECULAR PHARMACEUTICS, vol.13, no.6, pp.1822-1832, 2016 (SCI-Expanded)

2016

Colloidal nanocarriers for the enhanced cutaneous delivery of naftifine: characterization studies and in vitro and in vivo evaluations

Erdal M. S. , Ozhan G., Mat M. C. , Ozsoy Y., Gungor S.

INTERNATIONAL JOURNAL OF NANOMEDICINE, vol.11, pp.1027-1037, 2016 (SCI-Expanded)

2012

Comparison of Ga-DOTATATE and Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours

KABASAKAL L., Demirci E., OCAK E. M. , Decristoforo C., ARAMAN A. O. , ERGİNER Y., et al.

Eur J Nucl Med Mol Imaging, no.39, pp.1271-1277, 2012 (SCI-Expanded)

2012

Quality by design approach for tablet formulations containing spray coated ramipril by using artificial intelligence techniques

Aksu B., de Matas M., CEVHER E., ERGİNER Y., Güneri T., York P.

International Journal of Drug Delivery, no.4, pp.59-69, 2012 (SCI-Expanded)

2012

Plasticizers in Transdermal Drug Delivery Systems

Gungor S., Erdal M. S. , Ozsoy Y.

RECENT ADVANCES IN PLASTICIZERS, pp.91-112, 2012 (SCI-Expanded)

2011

Nasal route: an alternative approach for antiemetic drug delivery

Ozsoy Y., Gungor S.

EXPERT OPINION ON DRUG DELIVERY, vol.8, no.11, pp.1439-1453, 2011 (SCI-Expanded)

2011

Optimization of Alfuzosin HCl Tablet Formulations Using Artificial Neural Network

Mesut B., Aksu N. B. , Erginer Y.

European Journal Of Pharmaceutical Sciences, vol.44, no.1, pp.93-94, 2011 (SCI-Expanded)

2009

Nasal Delivery of High Molecular Weight Drugs

Ozsoy Y., Gungor S., Cevher E.

MOLECULES, vol.14, no.9, pp.3754-3779, 2009 (SCI-Expanded)

2006

The preparation of ciprofloxacin hydrochloride-loaded chitosan and pectin microspheres - Their evaluation in an animal osteomyelitis model

ERGİNER Y., CEVHER E.

JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, vol.88B, no.2, pp.270-275, 2006 (SCI-Expanded)

1997

Potential of particulate carriers for the mucosal delivery of DNA vaccines

ERGİNER Y.

BIOCHEMICAL SOCIETY TRANSACTIONS, vol.25, no.2, 1997 (SCI-Expanded)

1996

Genetic immunisation via mucosal and parenteral routes using microsphere carriers

ERGİNER Y.

CONTROLLED RELEASE SOCIETY. INTERNATIONAL SYMPOSIUM ON CONTROLLED RELEASE OF BIOACTIVE MATERIALS, vol.1996, pp.861-862, 1996 (SCI-Expanded)

1991

RAPARIN, A NEW HEPARINOID FROM RAPANA-VENOSA (VALENCIENNES)

ERGİNER Y., ÖZTÜRK B.

PHARMAZIE, vol.46, no.7, pp.547-548, 1991 (SSCI)

Articles Published in Other Journals

2022

Nanocrystal Technology: Increasing Oral Bioavailability of Low-Soluble Drugs

Erginer Y., Pirinçci Tok Y., Güngör S.

Istanbul University Institute of Health Sciences Journal of Advanced Research in Health Sciences, vol.5, no.1, pp.1-12, 2022 (Peer-Reviewed Journal)

2021

Estimating the Optimal Dexketoprofen Pharmaceutical Formulation with Machine Learning Methods and Statistical Approaches

Baskor A., Tok Y. P. , Mesut B., Ozsoy Y., Ucar T.

HEALTHCARE INFORMATICS RESEARCH, vol.27, no.4, pp.279-286, 2021 (ESCI)

2021

Examining the basic principles of quality by design (QbD) approach in analytical studies

MESUT B., Onal C., Aksu B., ERGİNER Y.

ISTANBUL JOURNAL OF PHARMACY, vol.51, no.2, pp.271-276, 2021 (ESCI)

2021

A Review On Current Perspective Of Gastroretentive Drug Delivery Systems Prioritising Floating Dosage Forms

Başarır N. S. , Mesut B., Erginer Y.

Sağlık Bilimlerinde İleri Araştırmalar Dergisi, vol.4, no.2, pp.43-64, 2021 (Peer-Reviewed Journal)

2021

Çözünürlüğü Düşük Olan Etken Maddeler İçin Farmasötik Yaklaşımlar ve Aprepitantın Çözünürlüğü

Erginer Y., Nazlı H., Mesut B.

FABAD J. Pharm. Sci., vol.46, no.3, pp.325-344, 2021 (Peer-Reviewed Journal)

2021

Preparation and in vitro studies of fixed-dose tablet combination of repaglinide and metformin

Sahin S., MESUT B., Durgun M. E. , Ozcelik E., ERGİNER Y.

ISTANBUL JOURNAL OF PHARMACY, vol.51, no.1, pp.26-34, 2021 (ESCI)

2021

Ozmotik Kontrollü İlaç Salım Sistemleri

Erginer Y., Pelen B., Özçelik E.

Journal of Literature Pharmacy Sciences, vol.10, no.1, pp.51-64, 2021 (Peer-Reviewed Journal)

2021

Stability indicating method development and validation of ranolazine extended release tablets

Durak E. A. , Kurtgöz İ., MESUT B., CEVHER E., Özsoy Y.

Acta Pharmaceutica Sciencia, vol.59, no.3, pp.419-434, 2021 (Scopus)

2021

Formulation development and evaluation of taste-masked atomoxetine hydrochloride orally disintegrating tablets (Odts)

Kazaz Ç., Mesut B., Özsoy Y., Ocak E. M.

Journal of Research in Pharmacy, vol.25, no.5, pp.715-727, 2021 (ESCI)

2021

Developing, optimization and in vitro evaluating of three-layers floating dipyridamole film in hard gelatine capsule

Ozcelik E., Sagıroglu A. A. , Ozsoy Y.

Acta Pharmaceutica Sciencia, vol.59, no.2, pp.253-273, 2021 (Refereed Journals of Other Institutions)

2020

Veteriner Alanda Kullanılan Modifiye Salımlı Dozaj Şekilleri

Erginer Y.

Türk Farmakope Dergisi, vol.5, no.2, pp.25-36, 2020 (Peer-Reviewed Journal)

2020

In vitro skin permeation and antifungal activity of naftifine microemulsions Naftifin mikroemülsiyonlarının in vitro deriden permeasyonu ve antifungal aktivitesi

Erdal M. S. , Gürbüz A., Birteksöz T., Güngör S., Özsoy Y.

Turkish Journal of Pharmaceutical Sciences, vol.17, no.1, pp.43-48, 2020 (ESCI)

2019

Yeni Dozaj Formları:Oral Filmler

Özcan Bülbül E., YILDIZ PEKÖZ A., ERGİNER Y.

Literatür Eczacılık Bilimleri, vol.1, pp.1-14, 2019 (Peer-Reviewed Journal)

2019

Formulation design and taste assessment in orally disintegrating tablets

KAZAZ Ç., OCAK DEMİRCİ E. M. , MESUT B., ERGİNER Y.

FABAD JOURNAL OF PHARMACEUTICAL SCIENCES, vol.44, no.2, pp.169-178, 2019 (Scopus)

2017

Quetiapine Fumarate Extended-release Tablet Formulation Design Using Artificial Neural Networks

Ozcelik E., Mesut B., Aksu B., Ozsoy Y.

TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, vol.14, no.3, pp.213-221, 2017 (ESCI)

2017

Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery

Kahraman E., Gungor S., Ozsoy Y.

THERAPEUTIC DELIVERY, vol.8, no.11, pp.967-985, 2017 (ESCI)

2017

BUDESONIDE SELF-NANOEMULSION FORMULATION AS AN ORAL DRUG DELIVERY SYSTEM: PREPARATION, CHARACTERIZATION AND CYTOTOXICITY STUDIES

Mesut B., Tekarslan Şahin Ş. H. , Erginer Y.

PressAcademia Procedia, vol.5, no.1, pp.41-46, 2017 (Peer-Reviewed Journal)

2017

Formulation Design of the Oral Disintegrating Tablets Including Alfuzosin Hydrochloride with Risk Evaluation via Quality by Design

GÜNCAN G., ERGİNER Y., Aksu B., MESUT B., Yeğen G.

Acta Pharm. Sci., vol.55, no.2, pp.57-76, 2017 (Peer-Reviewed Journal)

2017

Targeted drug delivery and vaccinology approaches using virus-like particles for cancer

Sereflioglu S., Yapici E., Sahin S. H. T. , Ozsoy Y., ÜSTÜNDAĞ C. B.

ISTANBUL JOURNAL OF PHARMACY, vol.47, no.3, pp.112-119, 2017 (ESCI)

2015

Ksantan Zamkının Uzatılmış Salımlı Tabletlerde Kullanımı

Özçelik E., MESUT B., ERGİNER Y.

Türkiye Klinikleri Eczacılık Bilimleri Dergisi, vol.4, no.2, pp.79-88, 2015 (Peer-Reviewed Journal)

2015

The Place of Drug Product Critical Quality Parameters in Quality by Design

Mesut B., Aksu B., Erginer Y.

TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, vol.12, pp.75-92, 2015 (Scopus)

2011

Transdermal films of metoclopramide hydrochloride with terpenes as penetration enhancers: Design, characterization, in vitroevaluation and ATR-FTIR spectroscopic investigation on excised pig skin

ERDAL M. S. , SAĞIRLI A. O. , ERGİNER Y.

Asian Chemistry Letters, vol.16, no.1, pp.67-78, 2011 (Peer-Reviewed Journal)

2010

POLYMERIC MICELLES AND ITS NASAL APPLICATIONS

KAHRAMAN ŞİRİN E., ERGİNER Y.

ISTANBUL JOURNAL OF PHARMACY, vol.41, pp.121-139, 2010 (ESCI)

2006

Preparation of ciprofloxacin hydrochloride loaded chitosan and pectin microspheres and their ın vivo evaluation in an animal experimental ımplant-related osteomyelitis model

Orhan Z., CEVHER E., Mülazımoğulu L., Gürcan D., Alper M., ARAMAN A. O. , et al.

Journal of Bone and Joint Surgery, pp.270-275, 2006 (Scopus)

2005

Büyük Moleküllü İlaçlar İçin Yeni Salım Sistemleri

ERGİNER Y.

Güncel Eczacılık, no.136, pp.24-26, 2005 (Non Peer-Reviewed Journal)

2005

Transgenik hayvanlar ve üretilen ilaç etkin maddeleri

ERGİNER Y., YILDIZ PEKÖZ A.

Güncel Eczacılık, no.128, pp.28-30, 2005 (Non Peer-Reviewed Journal)

2004

Vehicle effects on in vitro release of tiaprofenic acid from different topical formulations.

ÖZSOY ERGİNER Y., GÜNGÖR S., CEVHER E., ARAMAN A. O.

IL Farmaco, no.59, pp.563-566, 2004 (Peer-Reviewed Journal)

2003

Nazal yol ile ilaç uygulamaları

ERGİNER Y., YILDIZ PEKÖZ A.

Güncel Eczacılık, no.115, pp.19-23, 2003 (Non Peer-Reviewed Journal)

2003

In vitro studies on sustained release suppository formulations of tiaprofenic acid with sucre fatty acid ester

GÜNGÖR S., Orlu M., ÖZSOY ERGİNER Y., ARAMAN A. O.

SCIENTIA PHARMACEUTICA, no.71, pp.357-364, 2003 (Scopus)

2002

Katı dozaj şekillerinin tatlarının maskelenmesi

ERGİNER Y.

Güncel Eczacılık, no.100, pp.39-41, 2002 (Non Peer-Reviewed Journal)

2002

Enhanced Dissolution Rate of Tiaprofenic Acid Using Gelucire 44/14

ERDAL M. S. , ARAMAN A. O. , Uzunkaya G., ÖZSOY ERGİNER Y.

SCIENTIA PHARMACEUTICA, pp.295-307, 2002 (Scopus)

2001

Preparation of sustained-release tiaprofenic acid beads

YILDIZ PEKÖZ A., Şensoy D., Baytokova A., ÖZSOY ERGİNER Y., ARAMAN A. O.

Journal of Faculty of Pharmacy of Istanbul Univesity, vol.34, pp.27-33, 2001 (Peer-Reviewed Journal)

1998

Akne tedavisinde kullanılan ilaçlar

ERGİNER Y., Bergişadi N.

Güncel Eczacılık, no.56, pp.24-26, 1998 (Non Peer-Reviewed Journal)

1997

Öksüz ilaçlar (Orphan Drugs)

ERGİNER Y., GÜNGÖR S.

Aktüel Eczacı, vol.37, pp.25-30, 1997 (Non Peer-Reviewed Journal)

1996

INTERNET

ERGİNER Y.

Aktüel Eczacı, vol.26, pp.14-16, 1996 (Non Peer-Reviewed Journal)

1996

Sağlık ve Teknoloji

ERGİNER Y.

Sağlık, vol.2, pp.22-23, 1996 (Non Peer-Reviewed Journal)

1996

İnsan Nasıl Tembel Emek ile Rahatlıkla düNyayı Evine Taşır?

ERGİNER Y.

Aktüel Eczacı Sayı: 25. 34 (1996)., vol.25, pp.34-36, 1996 (Non Peer-Reviewed Journal)

1995

Comparison of paracetamol suppositories commercially available in Turkey

ARAMAN A. O. , ÖZSOY ERGİNER Y., GÜNGÖR S.

Acta Pharmaceutica Turcica, vol.37, no.4, pp.130-133, 1995 (Peer-Reviewed Journal)

1994

Investigation of the suppository base SF-9265 prepared in Turkey

ÖZSOY ERGİNER Y., ARAMAN A. O. , GÜNGÖR S.

Acta Pharmaceutica Turcica, vol.36, no.4, pp.96-101, 1994 (Peer-Reviewed Journal)

1993

Identification and determination of colorants in chewing gums and jellies

ARAMAN A. O. , ÖZSOY ERGİNER Y.

Acta Pharmaceutica Turcica, vol.35, pp.33-38, 1993 (Peer-Reviewed Journal)

1991

Determination of defibrotide based on bathochromasy

Erginer Y., Güven K.

Acta Pharmaceutica Sciencia, vol.33, no.1, pp.15-18, 1991 (Scopus)

1990

Adenozin Deaminaz Yetersizliği ve Adenozin Deaminaz Gen Değişim Terapisi

ERGİNER Y., ULUTİN A. N. T.

Dirim Sayı:3-4. 96-99 (1990)., pp.96-99, 1990 (Non Peer-Reviewed Journal)

1987

Turkey's Role in Science III. Study Using Corporate Index of SCI

Erginer Y., Güven K. C.

Acta Pharmaceutica Turcica, vol.29, pp.33-45, 1987 (Peer-Reviewed Journal)

Refereed Congress / Symposium Publications in Proceedings

2021

In vitro characterization of micelles based drug delivery systems for ocular fungal infections

Durgun M. E. , Mesut B., Güngör S., Erginer Y.

CRS Virtual Annual Meeting 2021, 25 - 29 July 2021

2021

Development of the Micellar Based Ocular In Situ Gelling Systems of Posaconazole with Quality by Design (QbD) Approach

Durgun M. E. , Mesut B., Güngör S., Erginer Y.

13th International Symposium on Pharmaceutical Sciences (ISOPS), 22 - 25 June 2021, pp.41-42

2021

Optimization Studies of Alfuzosin Tablet Formulation Using Machine Learning Models

Başkor A., Mesut B., Aksu N. B. , Erginer Y.

4th International Conference on Data Science and Applications (ICONDATA'21), Muğla, Turkey, 4 - 05 June 2021, pp.32

2021

Machine Learning Models and Statistical Dexketoprofen Pharmaceutical Dosage of Approaches Application In The Form

Başkor A., Pirinçci Tok Y., Mesut B., Erginer Y., Uçar T.

4th International Conference on Data Science and Applications (ICONDATA’21), Muğla, Turkey, 4 - 06 June 2021, pp.14

2021

Effect of Ingredients and Physicochemical Characteristics of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers on Drug Release Profiles

Üner B., Özdemir S., Taş Ç., Üner M., Erginer Y.

9. International Drug Chemistry Conference, Antalya, Turkey, 8 - 11 April 2021, pp.125

2021

Preparation of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Application in Treatment of Allergic Reactions of the Skin: Optimization of Formulation Parameters

Üner B., Özdemir S., Taş Ç., Üner M., Erginer Y.

Euro Asia 8th International Congress on Applied Sciences, Toskent, Uzbekistan, 15 - 16 March 2021, pp.248-255

2020

Design, Preparation and Evaluation of Taste-Masked Dexketoprofen of Orally Disintegrating Tablet By Using QbD Approach

Pirinçci Tok Y., Mesut B., Erginer Y.

The 1st International Electronic Conference on Pharmaceutics, Basel, Switzerland, 1 - 03 December 2020, pp.1

2020

D-α-tocopheryl Polyethylene Glycol 1000 Succinate (TPGS) Micelles Based In Situ Gelling Systems For Ocular Anti-fungal Therapy

Durgun M. E. , Güngör S., Erginer Y.

Controlled Release Society (CRS) Annual Virtual Meeting 2020, 29 June - 02 July 2020, pp.1

2020

Optimization and Characterization of Posaconazole Loaded Nanomicelles for Ocular Delivery

Güngör S., Durgun Kılıç M. E. , Kahraman E., Erginer Y.

XIII Spanish-Portuguese Conference on Controlled Drug Delivery, A-Coruna, Spain, 22 - 24 January 2020, pp.1-2

2019

Risk Assesment of Taste Masked Orally Disintegrating Tablets of Dexketoprofen

Pirinçci Tok Y., Mesut B., Erginer Y., Yetilmezsoy K.

7th International BAU Drug Design Congress, İstanbul, Turkey, 19 - 21 December 2019, pp.164

2019

Nanomicellar carriers of posaconazole: A novel approach to improve its ocular bioavailability

Durgun Kılıç M. E. , Kahraman E., Güngör S., Özsoy Y.

8th BBBB International Conference on Pharmaceutical Sciences, İzmir, Turkey, 14 - 16 October 2019, pp.1-2

2019

Bioequivalence assessment of generic topical gels using in vitro methods

Kalami E., Kahraman E., Dedeoğlu E., Gürbüz K., Güngör S., Özsoy Y.

8th BBBB International Conference on Pharmaceutical Sciences, İzmir, Turkey, 14 - 16 October 2019, pp.1-2

2019

Development of Melatonin-Containing Orally Disintegrated Tablets Using Artificial Intelligensys Methodology

Mesut B., Alkan B., Pirinçci Tok Y., Erginer Y., Yetilmezsoy K.

8th BBBB International Conference on Pharmaceutical Science, İzmir, Turkey, 14 - 16 October 2019, pp.72-73

2019

Self Nanoemulsifying Drug Delivery System Formulation Design of Aprepitant

Nazlı H., Mesut B., Erginer Y.

8th BBBB International Conference on Pharmaceutical Sciences, İzmir, Turkey, 14 - 16 October 2019, pp.138-139

2019

Preformulation Studies of Self Nanoemulsifying Drug Delivery System (SNEDDS) Formulation of Deferasirox

Alghananim A., Özalp Y., Mesut B., Güngör S., Erginer Y.

8th BBBB International Conference on Pharmaceutical Sciences , İzmir, Turkey, 14 - 16 October 2019, pp.285-286

2019

Development of Aripiprazole Orally Disintegrating Film Formulation By Using Quality by Design Approach

Mesut B., Kalayı M., Aksu B., Erginer Y.

8th BBBB International Conference on Pharmaceutical Sciences, İzmir, Turkey, 14 - 16 October 2019, pp.312-313

2019

Development and Mechanical Modeling of Si1-xGex/Si MQW Based Uncooled Microbolometers in a 130 nm BiCMOS

Baristiran-Kaynak C., Goeritz A., Yamamoto Y., Wictstruck M., Stocchi M., Unal K. E. , et al.

19th IEEE Topical Meeting on Silicon Monolithic Integrated Circuits in RF Systems (SiRF), Florida, United States Of America, 20 - 23 January 2019, pp.122-124

2018

The Application of Artificial Neural Networks for the Development of Topical Flurbiprofen Microemulsion

Mesut B., Gürbüz A., Erdal M. S. , Aksu B., Erginer Y., Güngör S.

12th Central European Symposium on Pharmaceutical Technology and Regulatory Affairs, Szeged, Hungary, 20 - 22 September 2018, pp.107-108

2018

Self Nanoemulsifying Drug Delivery System (SNEDDS) Formulation Design of Aprepitant

Nazlı H., MESUT B., tekarslan h., ERGİNER Y.

International Pharmaceutical Technology Symposium, Antalya, Turkey, 17 - 19 September 2018, pp.12

2018

Development and Optimization of Orodispesible Films Containing Quetiapine Fumarate

Özcan E., MESUT B., ERGİNER Y.

International Pharmaceutical Technology Symposium, Antalya, Turkey, 17 - 19 September 2018, pp.13

2017

QBD-Based Development and Characterisation of Microemulsion Formulations for Improved Skin Delivery of Flurbiprofen

GÜRBÜZ A., MESUT B., ERDAL M. S. , Aksu B., ERGİNER Y., GÜNGÖR S.

2nd International Gazi Pharma Symposium Series, Ankara, Turkey, 11 - 13 October 2017, pp.36

2017

Evaluation of cytotoxicity of of budesonide-loaded Snedds on human colon cancer cell lines

MESUT B., TEKARSLAN ŞAHİN Ş. H. , ERGİNER Y.

2nd International Gazi Pharma Symposium Series, İstanbul, Turkey, 11 - 13 October 2017, pp.96

2017

QbD based development and characterization of microemulsion formulations for improved skin delivery of flurbiprofen

GÜRBÜZ A., MESUT B., ERDAL M. S. , Aksu B., ERGİNER Y., GÜNGÖR S.

2nd International Gazi Pharma Symposium Series, Ankara, Turkey, 11 - 13 October 2017, pp.1

2017

Novel topical nano-carriers to improve penetration of tacrolimus into the skin

KAHRAMAN E., NEŞETOĞLU N., GÜNGÖR S., ÜNAL D. Ş. , ERGİNER Y.

FIP World Congress of Pharmacy and Pharmaceutical Sciences 2017, Seoul, South Korea, 10 - 14 September 2017

2017

Design of Extended Release Tablet Formulation Using Artificial Neural Network

Özçelik E., Mesut B., Aksu B., Erginer Y.

CRS Annual Meeting & Exposition, Massachusetts, United States Of America, 16 - 19 July 2017, pp.1

2017

Penetration Enhancer-Containing Nanomicelles for Topical Delivery: Impact on Skin Barrier

ERGİNER Y., KAHRAMAN E., GÜNGÖR S.

Controlled Release Society Annual Meeting & Exposition), Boston, United States Of America, 16 - 19 July 2017, pp.3487

2017

Budesonide Self-microemulsion Formulation as a oral Drug Delivery System

Mesut B., Erginer Y.

6th Pharmaceutical Sciences World Congress 2017, Stockholm, Sweden, 21 - 24 May 2017, pp.1

2017

Tacrolimus Loaded Pluronic®F127 Micelles: Cellular Viability and Cell Growth for Ocular Administration

KAHRAMAN E., KARACA M., TEKARSLAN ŞAHİN Ş. H. , YILDIZ PEKÖZ A., ERGİNER Y., GÜNGÖR S.

The 6th Pharmaceutical Sciences World Congress, Stockholm, Sweden, 21 - 24 May 2017

2017

Tacrolimus loaded Pluronic F127 micelles: Cellular viability and cell growth for ocular administration

KAHRAMAN E., KARACA M., TEKARSLAN ŞAHİN Ş. H. , YILDIZ PEKÖZ A., GÜNGÖR S., ERGİNER Y.

6th Pharmaceutical Sciences World Congress, Stockholm, Sweden, 21 - 24 May 2017

2017

Budesonide self-nanoemulsion formulation as an oral drug delivery system: Preparation,characterization and cytotoxicity studies

Mesut B., Tekarslan Şahin Ş. H. , Erginer Y.

2nd World Conference on Technology, Innovation and Entrepreneurship, İstanbul, Turkey, 12 - 14 May 2017, pp.54

2017

Improved drug localization in the skin via topical nano-micellar carriers

KAHRAMAN E., NEŞETOĞLU N., ÖZTAŞ E., ÖZHAN G., ÜNAL D. Ş. , GÜNGÖR S., et al.

22ND INTERNATIONAL BIOMEDICAL SCIENCE & TECHNOLOGY SYMPOSIUM, Ankara, Turkey, 12 - 14 May 2017

2017

Artificial Neural Networks in Pharmaceutical Technology

MESUT B., TEKARSLAN ŞAHİN Ş. H. , ERGİNER Y.

2nd World Conference on Technology, Innovation and Entrepreneurship, İstanbul, Turkey, 12 - 14 May 2017

2017

Implementing of Quality By Design Approach Using Different Computerized Systems

Mesut B., Aksu B., Erginer Y.

2nd European Conference on Pharmaceutics, Krakow, Poland, 3 - 04 April 2017, pp.1

2016

NİŞASTA ESASLI BİYOYAPIŞABİLEN POLİMERLERİN SENTEZİ VE İLAÇ TAŞIYIVI SİSTEMLERDE UYGULAMALARI

PABUCCUOĞLU S., PABUCCUOĞLU S. K. , DEMİR K., GÖK M. K. , CEVHER E., ERGİNER Y., et al.

ÜSİMP PATENT FUARI 16 ÜNİVERSİTE PATENTLERİ SANAYİ İLE BULUŞUYOR, 8-9 KASIM 2016, İstanbul, Turkey, 8 - 09 November 2016, pp.1

2016

The Importance of the Self Nano/Microemulsifying Drug Delivery Systems (SN/MEDDs) for Oral Drug Delivery

MESUT B., TEKARSLAN ŞAHİN Ş. H. , ERGİNER Y.

4th BAU DRUG DESIGN Congress, İstanbul, Turkey, 13 - 15 October 2016

2016

Development of topical microemulsions of naftifine and evaluation of their antifungal activity

ERDAL M. S. , GÜNGÖR S., BİRTEKSÖZ TAN A. S. , DÖŞLER S., ERGİNER Y.

4th Conference of Innovation in Drug Delivery, Antibes, France, 25 - 28 September 2016, pp.1

2016

Design and Optimization of Self-Nanoemulsifying Drug Delivery systems (SNEDDs) Containing Budesonide

MESUT B., ERGİNER Y.

International Pharmaceutical Technology Symposium, Antalya, Turkey, 18 - 21 September 2016, pp.172-174

2017

SNEDDs Formulation of Budesonide to İmprove its Solubility: Optimization and in vitro release studies

Erginer Y., Mesut B.

Drug Formulation & Bioavailability Congress, Beijing, China, 5 - 07 September 2017, pp.51

2016

Preliminary Studies on Topical Polymeric Micellar Formulations of Immunomodulatory Drugs

KAHRAMAN E., GÜNGÖR S., ÖZSOY Y.

Skin Forum 15th Annual Meeting, Londra, United Kingdom, 21 - 22 June 2016, pp.1-2

2015

Optimization of an orodispersible tablet formulation containing Metoprolol tartrate

ERGİNER Y., Yeğen G., Aksu B., CEVHER E.

2015 AAPS Annual Meeting and Exposition, Orlando, United States Of America, 25 - 29 October 2015, pp.1

2015

Importance Of Artificial Intelligence Applicatıons For Drug Development With Quality By Design (Qbd) Approach

ERGİNER Y., Yrğrn G., Aksu B., CEVHER E.

INTERNATIONAL MULTIDISCIPLINARY SYMPOSIUM ON Drug Research & Development (ILARUD), Eskişehir, Turkey, 25 - 29 October 2015, pp.1

2015

Formulation design and optimisation of oral disintegrating tablet containing Alfuzosin hydrochloride with Quality by Design Approach

ERGİNER Y., Güncan G., Yeğen G., Aksu B.

2015 AAPS Annual Meeting and Exposition, Orlando, United States Of America, 25 - 29 September 2015, pp.1

2015

Formulation design of the oral disintegrating tablets ıncluding alfuzosin hydrochloride with risk evaluation and artificial neural networks

ÖZSOY Y., AKSU B., GÜNCAN G., YEĞEN G.

BBBB 2015. 6th Baltic Bled Balatan Bosphorus Conference on Pharmaceutical Sciences, Helsinki, Finland, 10 - 12 September 2015, pp.10

2015

Risk Assessment Trials in The Aspect of Quality by Design

ERGİNER Y., Yeğen G., Aksu B., CEVHER E.

, International Eurasia Pharmacy Congress, Erzincan, Turkey, 3 - 07 September 2015, pp.1

2015

Optimization of Electrospun Nanofiber Mats for Transdermal Delivery

Gençtürk A., KAHRAMAN E., ÖZHAN G., GÜNGÖR S., ERGİNER Y., Saraç A. S.

Controoled Release Society Annual Meeting 2015, Edinburgh, United Kingdom, 26 - 29 July 2015, pp.1-2

2015

Quetiapine Fumarate Sustained Release Tablet Formulation Design By Using Inform V.4 ANN Program

Özçelik E., Mesut B., Aksu B., Erginer Y.

11th International Symposium on Pharmaceutical Sciences, Ankara, Turkey, 9 - 12 June 2015, pp.129

2015

Design of an orally disintegrating tablet formulation containing Metoprolol tartrate with the help of artificial intelligence programs,

ERGİNER Y., Yeğen G., Aksu B., CEVHER E.

Istanbul University World Conference On Technology, Innovation And Entrepreneurship, İstanbul, Turkey, 28 - 30 May 2015, pp.1

2015

A Novel Vaginal Tablet For The Estrous Synchronization In Sheeps

GÖK M. K. , PABUCCUOĞLU S. K. , DEMİR K., CİRİT Ü., CEVHER E., ERGİNER Y., et al.

II. International VETistanbul Group Congress, St.Petersburg, Russia, 7 - 09 April 2015, pp.666-667

2014

VEHICLE COMPOSITION EFFECTS ON IN VITRO TRANSSCLERAL IONTOPHORETIC TRANSPORT OF MOXIFLOXACIN

MESUT B., ERGİNER Y., GÜNGÖR S.

17th International Pharmaceutical Technology Symposium, Antalya, Turkey, 8 - 10 September 2014, pp.294-296

2014

The design of an orodispersible tablet formulation containing metoprolol tartrate with the quality by design (QbD) approach

ERGİNER Y., Yeğen G., Aksu B., CEVHER E.

17th International Pharmaceutical Technology Symposium - IPTS, Antalya, Turkey, 8 - 10 September 2014, pp.1

2014

Optimisation of ondansetron orally disintegrating tablets using artificial neural networks

ERGİNER Y., Aksu B., Yeğen G., PURİSA S., CEVHER E.

17th International Pharmaceutical Technology Symposium - IPTS, Antalya, Turkey, 8 - 10 September 2014, pp.1

2014

IN VITRO TRANSSCLERAL IONTOPHORESIS OF MOXIFLOXACIN HYDROCHLORIDE

MESUT B., ERGİNER Y., GÜNGÖR S.

41st Annual Meeting & Exposition of the Controlled Release Society, Chicago, United States Of America, 13 - 16 July 2014, pp.125

2014

Optimisation of ondansetron orally disintegrating tablets using artificial neural networks.

ERGİNER Y., Aksu B., Yeğen G., PURİSA S., CEVHER E.

2014 AAPS Annual Meeting and Exposition, San Diego, United States Of America, 19 - 21 May 2014, pp.1

2014

Optimization Studies of Quetiapine Fumarate Modified Release Tablets By Using Artificial Neural Network Programs

Özçelik E., Mesut B., Aksu B., Erginer Y.

9th World Meeting on Pharmaceutics, Biopharmaceutics, and Pharmaceutical Technology, Lisbon, Portugal, 31 March - 03 April 2014, pp.1-2

2013

Quetiapine Fumarate Modified Release Tablet Formulations Optimization Based on Genetic Algorithm Program

Özçelik E., Mesut B., Aksu B., Erginer Y.

International Multidisciplinary Symposium on Drug Research & Development, Antalya, Turkey, 28 - 30 November 2013, pp.1

2013

Quetiapine fumarate sustained release tablet formulations design by using artificial neural network

Östrusun Kontrolü Amaçlı Hormon Salımında Kullanılabilen Mukozaya Yapışabilen Polimerlerin Üretimi

GÖK M. K. , PABUCCUOĞLU S. K. , CEVHER E., ERGİNER Y., Bacınoğlu S., Cirit Ü., et al.

IV. Ulusal Reprodüksiyon ve Suni Tohumlama Bilim Kongresi, Antalya, Turkey, 25 - 28 October 2007, pp.60-61

Östrusun Kontrolu Amaçlı Hormon Salımında Kullanılabilen Mukozaya Yapışan Polimerlerin Üretimi

GÖK M. K. , ÖZGÜMÜŞ S., CEVHER E., BACINOĞLU S., ERGİNER Y., CİRİT Ü., et al.

4. Ulusal Reprodüksiyon Ve Suni Tohumlama Kongresi, Antalya, Turkey, pp.60-61

2007

Heparin’in uygulanmasında yeni Farmasötik yaklaşımlar

ERGİNER Y.

VII.Ulusal Tromboz, Hemostaz ve Anjioloji Kongresi, Adana, Turkey, 4 - 06 May 2007, pp.1

2007

Düşük Molekül Ağırlıklı Heparinin Jel Formülasyonları Üzerine In-Vitro Çalışmalar

ERGİNER Y., YILDIZ PEKÖZ A., GÜNGÖR S., ARAMAN A. O.

VII. Ulusal Tromboz, Hemostaz ve Anjioloji Kongresi, Adana, Turkey, 4 - 06 May 2007, pp.1

2007

in vitro and in vivo studies on ondansetron HCl loaded biodegradable mıcrospheres

ERGİNER Y., GÜNGÖR S., OKYAR A., TOKER S., Baktır G.

Pharmaceutical Sciences World Congress, Amsderdam, Netherlands, 22 - 25 April 2007, pp.1

2007

Primary Packaging for Pharmaceuticals and its Importance for the Future

ERGİNER Y., ARAMAN A. O.

SHOTT Pharma Symposium, İstanbul, Turkey, 14 March 2007, pp.1

2006

Nazal yolla uygulanan modern terapötik sistemler

ERGİNER Y.

50. Yıl İstanbul Eczacı Odası İstanbul Eczacılık Kongresi, İstanbul, Turkey, 8 - 10 December 2006, pp.1

2006

İlaçların nazal yoldan uygulanması

ERGİNER Y.

Mediterranean Pharmacy Congress, Antalya, Turkey, 13 - 16 October 2006, pp.1

2006

Heparin Microparticles for Pulmonary Administration

ERGİNER Y., YILDIZ PEKÖZ A., ARAMAN A. O.

33rd Annual Meeting & Exposition of the Controlled Release Society, Vienna, Austria, 22 - 26 July 2006, pp.1

2006

Vücutta Parçalanabilen Heparin Mikrokürelerinin Nazal Yol ile Uygulanması

ERGİNER Y., YILDIZ PEKÖZ A., OKYAR A., Baktır G., ARAMAN A. O.

VI. Ulusal Tromboz, Hemostaz ve Anjiolojik Kongresi, İzmir, Turkey, 5 - 07 May 2006, pp.1

2006

Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylocuccus aureus (MRSA) with prepared microspheres

ERGİNER Y., CEVHER E., Orhan Z., Müzazımoğlu L., Şensoy D., Alper M., et al.

5th World Meeting on Pharmaceutics and Pharmaceutical Technology, Cenevre, Switzerland, 27 - 30 March 2006, pp.1

2005

Effects of terpenes on Verapamil HCl permeation through excised rat skin from matrix-type transdermal systems and pharmacodynamic activity

GÜNGÖR S., Bektaş A., ALP F. İ. , ÖZSOY ERGİNER Y., UYDEŞ DOĞAN B. S. , ARAMAN A. O. , et al.

Pharmaceutical Sciences Fair& Exhibition, EUFEPS, Nice, France, 12 - 17 June 2005, pp.1

2005

Effect of terpenes on verapamil hydrochloride permeation through excised rat skin from matrix-type transdermal systems and pharmacodynamic activity in rats

ERGİNER Y., GÜNGÖR S., BEKTAŞ A., ALP YILDIRIM F. İ. , UYDEŞ DOĞAN B. S. , ÖZDEMİR O., et al.

PharmSciFair, Pharmaceutical Sciences Fair & Exhibition, Nice, France, 12 - 17 June 2005, pp.1

2004

Preparation of Ciprofloxacin HCl Loaded Microspheres and In vivo Evaluation with Orthopaedics Studies

ERGİNER Y., ORHAN Z., CEVHER E., Mülazımoğlu L., GÜRCAN D., ARAMAN A. O.

Pharmaceutical Sciences World Congress (PSWC 2004), Kyoto, Japan, 30 May - 03 June 2004, pp.1

2004

In vitro and In vivo Evaluation of Ciprofloxacin HCl Loaded Chitosan Microspheres by Spray-Drying Method and In Vivo Evaluation for Nasal Administration

ERGİNER Y., GÜRCAN D., OKYAR A., KARAKOÇ B., BAKTIR G., GERÇEKER A.

European Conference on Drug Delivery and Pharmaceutical Technology, Sevilla, Spain, 10 - 12 May 2004, pp.1

2004

Biodegredable heparin microspheres: II. Nasal administration of heparin microspheres

ERGİNER Y., YILDIZ PEKÖZ A., OKYAR A., ARAMAN A. O. , BAKTIR G.

5th International Conference and Workshop on Cell Culture and In-vitro models for Drug Absorption and Delivery, Saarbrücken, Germany, 25 February - 05 March 2004, pp.1

2003

In vitro studies on topical gel formulations of low molecular weight heparin

ERGİNER Y., YILDIZ PEKÖZ A., GÜNGÖR S., ARAMAN A. O.

Symposium Skin and Formulation, Paris, France, 23 - 24 October 2003, pp.1

2003

Preliminary in vitro studies on transdermal matrix formulations of verapamil hydrochloride using pectin

ERGİNER Y., GÜNGÖR S., BEKTAŞ A., ARAMAN A. O.

Symposium Skin and Formulation, Paris, France, 23 - 24 October 2003, pp.1

2002

Studies on topical formulations of tiaprofenic acid

ERGİNER Y., GÜNGÖR S., CEVHER E.

3rd International Postgraduate Research Symposium on Pharmaceutics, İstanbul, Turkey, 16 - 18 September 2002, pp.1

2002

Studies on indomethacin loaded microparticles with glyceryl behenate

ERGİNER Y., ERDAL M. S. , GÜNGÖR S., ARAMAN A. O.

3rd International Postgraduate Research Symposium on Pharmaceutics, İstanbul, Turkey, 16 - 18 September 2002, pp.1

2002

Preliminary Studies on Sustained Release Suppository Formulations of Tiaprofenic Acid with Sucrose Ester

ERGİNER Y., GÜNGÖR S., ORLU M., ARAMAN A. O.

11th International Pharmaceutical Technology Symposium, İstanbul, Turkey, 9 - 11 September 2002, pp.1

2000

Preparation of Sustained-release Tiaprofenic Acid Beads

ERGİNER Y., YILDIZ PEKÖZ A., ŞENSOY D., Baytokova A.

The Second International Postgraduate Research Symposium on Pharmaceutics, İstanbul, Turkey, 6 - 08 September 2000, pp.1

2000

Investigations on Mefenamic Acid Sustained-Release Tablets with Water-Insoluble Gel

ERGİNER Y., YILDIZ PEKÖZ A., GÜNGÖR S., CEVHER E., ARAMAN A. O.

The Second International Postgraduate Research Symposium on Pharmaceutics, İstanbul, Turkey, 6 - 08 September 2000, pp.1

2000

Effects of Gelucire?44/14 on the Dissolution of Tiaprofenic Acid from Hard Gelatin Capsules

ERGİNER Y., ERDAL M. S. , UZUNKAYA G., ŞENSOY D., ARAMAN A. O.

The Second International Postgraduate Research Symposium on Pharmaceutics, İstanbul, Turkey, 6 - 08 September 2000, pp.1

1998

In vivo studies on the nasal preparations of ciprofloxacin hydrochloride

ERGİNER Y., Tunçel T., CAN A., AKEV N., BİRTEKSÖZ TAN A. S. , GERÇEKER A.

Hacettepe University, 9 th International Pharmaceutical Technology Symposium, Turkey, 1 - 04 December 1998, pp.91

1996

Genetic immunisation via mucosal and parenteral routes using microsphere carriers

Alpar H., ERGİNER Y. , Bowen J., Eyles J., Conway B., Williamson E.

23rd International Symposium on Controlled Release of Bioactive Materials, Kyoto, Japan, 7 - 10 July 1996, pp.861-862

1989

THE PHARMACOLOGY AND CLINICAL-PHARMACOLOGY OF DEFIBROTIDE - A NEW PROFIBRINOLYTIC, ANTITHROMBOTIC AND ANTIPLATETLET SUBSTANCE

ULUTIN O., BALKUVULUTIN S., UGUR M., ULUTIN T., ERGİNER Y., CIZMECI G.

INTERNATIONAL SCIENTIFIC SYMP ON FIBRINOGEN, THROMBOSIS, COAGULATION, AND FIBRINOLYSIS, Taipei, Taiwan, 30 August - 01 September 1989, vol.281, pp.429-438

Books & Book Chapters

2021

Frontiers in Anti-infective Agents

Durgun Kılıç M. E. , Güngör S., Erginer Y.

Bentham Science Publishing, Singapore, 2021

2021

Anti-Infective Agents in Ocular Treatment and New Approaches

Durgun M. E. , Güngör S., Erginer Y.

in: Frontiers in Anti-infective Agents, Singh P.,Kumar V.,Karpoormath R., Editor, Bentham Science Publishers, Singapore, pp.1-41, 2021

2020

Recent advances in biopolymer-based transdermal patches

Güngör S., Kahraman E., Erdal M. S. , Özsoy Y.

in: Biopolymer Membranes and Films, Health, Food, Environment, and Energy Applications, Mariana Agostini de Moraes,Classius Ferreira da Silva,Rodrigo Silveira Vieira, Editor, Elsevier Science, Oxford/Amsterdam , Chennai, pp.195-217, 2020

2019

Phytosomes as Novel Carriers of Herbal Extracts

Güngör S., Akbal Dağıstan Ö., Algın Yapar E., Kartal M., Erginer Y.

in: Novel Drug Delivery Systems for Phytoconstituents, Gupta M,Chauhan D.A.,Sharma V,Chauhan N.S., Editor, Crc Press, Florida, pp.69-81, 2019

2019

Polymeric micelles as a novel carrier for ocular drug delivery

Özsoy Y., Güngör S., Kahraman E., Durgun M. E.

in: Nanoarchitectonics in Biomedicine, Grumezescu AM, Editor, William Andrew Publishing , New York, pp.85-117, 2019

2019

Polymeric micelles as a novel carrier for ocular drug delivery

Erginer Y.

in: Nanoarchitectonics in Biomedicine, Alexandru Mihai Grumezescu, Editor, Elsevier Science, Oxford/Amsterdam , New-York, pp.85-117, 2019

2017

EczÇEP-Eczacılık Fakülteleri Müfredat Detay Çalışması

Akalın E., Akev N., Erginer Y., Güzeldemirci N., Toker S., Kolak U., et al.

Kapitta Yayıncılık, Ankara, 2017

2017

EczÇEP- Eczacılık Fakülteleri Müfredat Detay Çalışması

Akalın Uruşak E., Akev N., Erginer Y., Güzeldemirci N., Toker S., Kolak U., et al.

Kapitta Yayıncılık, Ankara, 2017

2016

Dermal and Transdermal Drug Delivery Systems

GÜNGÖR S., ERDAL M. S. , ERGİNER Y.

in: Encyclopedia of Biomedical Polymers and Polymeric Biomaterials, Munmaya KM., Editor, Taylor And Francis, New York, pp.2606-2619, 2016

2015

Polymeric micelles for cutaneous drug delivery

GÜNGÖR S., KAHRAMAN E., ERGİNER Y.

in: Nano Based Drug Delivery, Naik J., Editor, Iapc Publishing, Zagreb, pp.369-384, 2015

2014

Miseller

ERGİNER Y.

in: Nanofarmasötikler ve Uygulamaları, Zırh Gürsoy A., Editor, Aktif Matbaa Ve Reklam Hizm.San.Tic. Ltd.,, İstanbul, pp.111-123, 2014

2014

Nanotaşıyıcıların aşı uygulamasında kullanılması

ERGİNER Y.

in: Nanofarmasötikler ve Uygulamaları, Zırh Gürsoy A., Editor, ), Aktif Matbaa Ve Reklam Hizm.San.Tic. Ltd.,, İstanbul, pp.283-0, 2014

2014

Nanopartiküllerin gen tedavisinde kullanılması

ERGİNER Y.

in: Nanofarmasötikler ve Uygulamaları, Zırh Gürsoy A., Editor, Aktif Matbaa Ve Reklam Hizm.San.Tic. Ltd, İstanbul, pp.267-277, 2014

2012

Plasticizers in Transdermal Delivery Systems

GÜNGÖR S., ERDAL M. S. , ERGİNER Y.

in: Plasticizers, Luqman M., Editor, Intech, Rijeka, pp.91-112, 2012

2012

Polymeric nanoparticles applied via nasal route.

ERGİNER Y., YILDIZ PEKÖZ A., GÜNGÖR S.

in: Polymeric nanoparticles applied via nasal route., Şenyiğit T., Özcan İ., Özer Ö, Editor, Nanotechnology İn Progress: Pharmaceutical Applications,, Research Signpoint, Kerala, India, Chapter, pp.95-109, 2012

2011

Novel formulation approaches for topical and transdermal delivery of non-steroidal antiinflammatory drugs

OKYAR A., ERGİNER Y., GÜNGÖR S.

in: Rheumatoid Arthritis– Treatment, Lemmey A., Editor, Intech, Rijeka, pp.25-48, 2011

2008

Particulate Carriers for Nasal Administration

ERGİNER Y.

in: Handbook of Particulate Drug Delivery Vol.2: Applications, KUMAR MNR, Editor, American Scientific Publishers , California, pp.143-164, 2008

2004

Göz, Kulak ve Buruna Uygulanan Dozaj Şekilleri

ERGİNER Y.

in: Farmasötik Teknoloji –Temel Konular ve Dozaj Şekilleri-, ZIRH GÜRSOY A., Editor, Piksel Bilişim Matbaacılık Ve Filmcilik Hizmetleri Ltd. Şti.,, İstanbul, pp.233-244, 2004

2004

Veteriner tedavideki dozaj şekilleri

ERGİNER Y.

in: Kontrollü Salım Sistemleri Derneği, Gürsoy A.Z., Editor, Piksel Bilişim Matbaacılık Ve Filmcilik Hizmetleri Ltd. Şti., İstanbul, pp.233-244, 2004

2002

Kontrollü Salım Sistemlerinin Veteriner Tedavide Kullanımı

ERGİNER Y., ARAMAN A. O.

in: Kontrollü Salım Sistemleri, ZIRH GÜRSOY A., Editor, Elma Bilgisayar Basım Ve Ambalaj San. Tic. Ltd. Şti, İstanbul, pp.371-382, 2002

2000

Farmasötik Teknoloji ve Kozmetoloji Laboratuvar Kitabı

Alpmen G., Altınkurt T., Bergişadi N., Topaloğlu Y., Tuncel T., ARAMAN A. O. , et al.

Ab Ofset, İstanbul, 2000

1990

THE PHARMACOLOGY AND CLINICAL-PHARMACOLOGY OF DEFIBROTIDE - A NEW PROFIBRINOLYTIC, ANTITHROMBOTIC AND ANTIPLATETLET SUBSTANCE

ERGİNER Y.

in: ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, LIU CY, CHIEN S., Editor, Acad Sınıca; Natl Scı Councıl, Dept Hlth; Fdn Bıomed Scı, Taipei, pp.429-438, 1990

Episodes in the Encyclopedia

2015

Encyclopedia of Biomedical Polymers and Polymer Biomaterials

Erdal M. S. , Güngör S., Erginer Y.

Taylor And The Francis Press, pp.2606-2619, 2015

Other Publications

2016

ALFUZOSİN'İN UZATILMIŞ SALIMLI TABLET FORMÜLASYONU TR İNCELEMESİZ PATENT NO: TR 2012/06229

MESUT B., ERGİNER Y., Aksu B., ARAMAN A. O.

Other, pp.15, 2016

2016

KETİAPİN’İN UZATILMIŞ SALIMLI TABLET FORMÜLASYONU TR PATENT BAŞVURUSU NO:TR 2013-G-316804

ERGİNER Y., Özçelik E., MESUT B., Aksu B., ARAMAN A. O.

Other, pp.11, 2016

2015

Nişasta esaslı biyo yapışabilen polimerlerin sentezi ve ilaç taşıyıcı sistemlerde uygulamaları, TR PATENTİ No: TR 2012 03191

PABUCCUOĞLU S. K. , GÖK M. K. , DEMİR K., Cirit Ü., CEVHER E., ERGİNER Y., et al.

Other, pp.20, 2015

Supported Projects

2020 - 2027

YENİLİKÇİ STERİL LİYOFİLİZE TOZ VE LİKİT ÜRÜNLER İLE STERİL OFTALMİK ÜRÜNLERİN GELİŞTİRİLMESİ, OPTİMİZASYONU VE ENDÜSTRİYEL ÜRETİMLERİ

TUBITAK Project

Erginer Y. (Executive)

2019 - 2026

ORAL, PARENTERAL, DERMAL VE OFTALMİK UYGULANMAK ÜZERE NANOTEKNOLOJİK YÖNTEMLERLE İLAÇLARIN BİYOYARARLANIMLARININ ARTTIRILMASI AMACIYLA FORMÜLASYONLARIN GELİŞTİRİLMESİ, KARAKTERİZASYONU VE ENDÜSTRİYEL UYGULAMALARI

TUBITAK Project

Erginer Y. (Executive)

2020 - 2022

Oküler Uygulamaya Yönelik Posakonazol Yüklü Miseler InSitu Jelleşen Sistemlerin Geliştirilmesi Karakterizasyonu In Vitro ve Ex Vivo ile Değerlendirilmesi

Project Supported by Higher Education Institutions

ERGİNER Y. (Executive), DURGUN KILIÇ M. E.

2019 - 2021

Çözünürlüğü düşük etkin maddenin kendiliğinden emülsifiye olan yeni formülasyonlarının geliştirilmesi, in vitro ve in vivo olarak değerlendirilmesi

Project Supported by Higher Education Institutions

ERGİNER Y. (Executive), NAZLI H., ÖZTÜRK D., MESUT B., OKYAR A.

2018 - 2020

Yapay Zeka Teknolojisi Kullanarak Tasarım ile Kalite Yaklaşımı Çerçevesinde Melatonin İçeren Ağızda Dağılan Tablet ODT Formülasyonun Geliştirilmesi In vitro ve Sitotoksisite Analizleri

Project Supported by Higher Education Institutions

MESUT B. (Executive), ERGİNER Y., YETİLMEZSOY K., TEKARSLAN ŞAHİN Ş. H.

2018 - 2020

2008 - 2008

NAZAL YOLLA UYGULANMAK ÜZERE ONDANSETRON HCL?IN KİTOZAN MİKROKÜRELERİ ÜZERİNDE İN VİTRO VE İN VİVO ÇALIŞMALAR

Nişasta Esaslı biyoyapışabilen polimerlerin sentezi ve ilaç taşıyıcı sistemlerde uygulamaları

Patent

2014

Extended Release Tablet Formulations of Quetiapine

Patent

Pending / Applied, The Invention Recourse Number: , Registration in Multiple Countries

2013

Ketiapin'in Uzatılmış Salımlı Tablet Formülasyonu

Patent

2017 - 2018

Istanbul University, Faculty Of Pharmacy , Department of Pharmaceutical Technology, Turkey

5th International Pharmaceutical Technology Symposium

Attendee

Ankara-Turkey

Citations

September 2001

Post Graduate

SINAV JÜRİSİ - Selen Kalava,

June-2001

June 2001

Post Graduate

SINAV JÜRİSİ - Emine Kazancıoğlu

Scientific Research / Working Group Memberships

2000 - 2015

İstanbul Üniversitesi Biyoteknoloji Ve Genetik Mühendisliği Araştırma Ve Uygulama Merkezi Genel Kurulu Üyeliği

https://biyogem.istanbul.edu.tr/tr/_

Istanbul University, Turkey

Announcements & Documents

Ruhsat Tanımlar

Lecture Note

1/9/2020

TANIMLAR.pdf

Tıbbi Cihaz

Lecture Note

1/9/2020

MEDİKAL BİYOMEDİKAL CİHAZ VE ÜRÜNLE....pdf

Farm Tekn II

Lecture Note

5/8/2018

ENJEKSIYONLUK PREP 2018.pdf

Farmasötik Biyoteknoloji Dersi-2

Lecture Note

5/8/2018

Biyoteknolojik+Ürün+Hazırlama.pdf

Farmasötik Biyoteknoloji Dersi-1

Lecture Note

5/8/2018

Farmasötik+Biyoteknoloji+Giris.pdf

SOP Örneği

Lecture Note

5/8/2018

SOP+ORNEGI.pdf

Talimat Örneği

Lecture Note

5/7/2018

Talimat Ornegi.pdf

Enjeksiyonluk Preparatlar 2018

Lecture Note

5/7/2018

ENJEKSIYONLUK PREP 2018.pdf

Farmasötik Biyoteknoloji Dersi

Lecture Note

5/2/2018

Biyoteknolojik Ürün Hazırlama.pdf

Farmasötik Biyoteknoloji Dersi

Lecture Note

5/2/2018

Farmasötik Biyoteknoloji Giris.pdf

GMP 2018

Lecture Note

4/19/2018

GMP fakulte.pdf

VALİDASYON 2018

Lecture Note

4/19/2018

validasyon.pdf

Farm Tekn II-Ölçek Büyütme

Lecture Note

3/13/2018

Ölçek Büyütme (Scale-up).pdf

Farm Tekn II-Enjeksiyonluk Preparatlar 2018

Lecture Note

3/13/2018

ENJEKSIYONLUK PREP 2018 .pdf

Farm Tekn II-Hesaplamalar 2018

Lecture Note

3/13/2018

HESAPLAMALAR 2018.pdf

İlaç Müh-Emülsiyon- Süspansiyon üretim

Lecture Note

3/13/2018

EMULSIYON VE SUSPANSIYON.pdf

İlaç Müh- Göz Merhemi üretimi

Lecture Note

3/13/2018

GÖZ MERHEMİ ÜRETİMİ.pdf

İlaç Müh-Krem üretimi

Lecture Note

3/13/2018

KREM ÜRETİMİ.pdf

ilaç Müh-Şurup üretimi

Lecture Note

3/13/2018

ŞURUP ÜRETİMİ.pdf

Ruhsat-Modül 3

Lecture Note

12/19/2017

MODÜL 3 farm gelişim.pdf

Patent çeşitleri

Lecture Note

12/19/2017

PATENT CESITLERI.pdf

Patent-farmasötik patent çeşitleri

Lecture Note

12/19/2017

Farmasötik patent çeşitleri .pdf

Ruhsat-Ölçek büyütme

Lecture Note

12/19/2017

Ölçek Büyütme (Scale-up).pdf

Ruhsat-Stabilite

Lecture Note

12/19/2017

stabilite TITCK 2017.pdf

Ruhsat-Talimat örneği

Lecture Note

12/19/2017

Talimat örnegi.pdf

Ruhsat-Sop Örneği

Lecture Note

12/19/2017

SOP ORNEGI.pdf

Ruhsat-Farmasötik Gelişim

Lecture Note

12/19/2017

FARMASOTİK_GELISIM.pdf

Vajinal ve Rektal sistemler

Lecture Note

12/18/2017

VAJINAL ve REKTAL SISTEMLER.pdf

Nano taşıyıcılı sistemler

Lecture Note

12/18/2017

NANO TAŞIYICILLI SİSTEMLER.pdf

Kolona ilaç taşıyan sistemler

Lecture Note

12/18/2017

KOLONA ilaç taşıyan sistemler.pdf

Patent Farm.Tekn III

Lecture Note

12/18/2017

PATENT DERSI F.TEKN III.pdf

Transdermal sistemler

Lecture Note

12/18/2017

TRANSDERMAL SİSTEMLER.pdf

Oral sistemler

Lecture Note

12/18/2017

ORAL SİSTEMLER.pdf

Oküler sistemler

Lecture Note

12/18/2017

OKÜLER SİSTEMLER.pdf

nazal sistemler

Lecture Note

12/18/2017

NAZAL SISTEMLER.pdf

mukozaya yapışan sistemler

Lecture Note

12/18/2017

MUKOZAYA YAPIŞAN SİSTEMLER.pdf

İlaçta Patent Seçimlik Dersi

Lecture Note

11/2/2017

Ders sunumu

Arge ve inovasyon.pdf

ilaçların Ruhsatlandırılması

Lecture Note

11/2/2017

Ders sunumu

RUHSAT_MODÜL 1.pdf

İlaçların Ruhsatlandırılması

Lecture Note

11/2/2017

Ders sunumu

RUHSAT_TANIMLAR.pdf

İlaçta Patent Seçimlik Dersi

Lecture Note

11/2/2017

Ders sunumu

PATENTİN KORUMA KAPSAMI.pdf

İlaçta Patent Seçimlik Dersi

Lecture Note

11/2/2017

Ders sunumu

İnternette Patent Taraması.pdf

İlaçta Patent Seçimlik Dersi

Lecture Note

11/2/2017

Lisans Dersi sunumları ektedir.

PATENT DERSİ_ANLASMALAR.pdf